Fourrts Global
SFA Login
- State-of-the-art facility with a built up area of 19230 Sq. meters
- F & D Set-up equivalent to miniature production facility
- HVAC and Water Purification Systems in line with CGMP standards
- 100% Export Oriented Unit
- UK MHRA & EU GMP Approved Site
- Also approved for supplies to Australia, Canada and Ethiopia
- Manufacturing Tablets and Capsules
- Production Capacity – 3 billion tablets, 350 million capsules
- 3 Granulation, 5 Compression, 4 Coating and 9 Packaging (including 1 Bulk Packaging line)
- Manufacture of Site Transfer/Tech Transfer products for UK, EU, Australian and Canadian customers
- Doing Product Development Projects for Regulated and Emerging Markets
- Approved by Mylan and Aurobindo
- USFDA Plant Approval is expected by Mar 2023